JP Morgan: Let the RNA Rumpus start!
This article was originally published in Scrip
Among the usual flurry of biopharma news announcements that has attended the JP Morgan Healthcare Conference (13-16 January, 2014; San Francisco), there has been a noteworthy sub-flurry of news from RNA-focused businesses.
You may also be interested in...
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.
INFOGRAPHIC: A snapshot of the compensation packages granted to the chiefs of the world’s biggest pharma companies, along with key performance stats for the businesses they lead.